{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:45:22Z","timestamp":1786884322000,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejmech.2024.117198","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T16:43:51Z","timestamp":1735058631000},"page":"117198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Design, synthesis and biological evaluation of galantamine analogues for cognitive improvement in Alzheimer's disease"],"prefix":"10.1016","volume":"284","author":[{"given":"Mengzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8906-8230","authenticated-orcid":false,"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9073-4806","authenticated-orcid":false,"given":"Maosheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2024.117198_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer's disease","volume":"24","author":"Hung","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"16","key":"10.1016\/j.ejmech.2024.117198_bib2","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1021\/acschemneuro.4c00150","article-title":"Repurposing anidulafungin for Alzheimer's disease via fragment-based drug discovery","volume":"15","author":"Xie","year":"2024","journal-title":"ACS Chem. Neurosci."},{"issue":"16","key":"10.1016\/j.ejmech.2024.117198_bib3","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1021\/acs.jmedchem.4c01132","article-title":"Discovery of 4-(arylethynyl)piperidine derivatives as potent nonsaccharide O-GlcNAcase inhibitors for the treatment of Alzheimer's disease","volume":"67","author":"Cheng","year":"2024","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.117198_bib4","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/med.21719","article-title":"A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy","volume":"41","author":"Gadhave","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.117198_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnmol.2019.00204","article-title":"New insights into cholinergic neuron diversity","volume":"12","author":"Ahmed","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117198_bib6","first-page":"759","article-title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expet Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.ejmech.2024.117198_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s41061-023-00426-9","article-title":"Spectroscopic determination of acetylcholine (ACh): a representative review","volume":"381","author":"\u015awit","year":"2023","journal-title":"Top. Curr. Chem."},{"issue":"47","key":"10.1016\/j.ejmech.2024.117198_bib8","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ejmech.2024.117198_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/ph16020179","article-title":"An overview of 1,2,3-triazole-Containing hybrids and their potential anticholinesterase activities","volume":"16","author":"Khan","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.117198_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112273","article-title":"The structure-based optimization of \u03b4-sultone-fused pyrazoles as selective BuChE inhibitors","volume":"201","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2024.117198_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jep.2004.02.012","article-title":"Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge","volume":"92","author":"Heinrich","year":"2004","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117198_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejmech.2009.09.045","article-title":"Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine","volume":"45","author":"Koteswara Rao","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117198_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuro.2016.10.013","article-title":"Galanthamine decreases genotoxicity and cell death induced by \u03b2-amyloid peptide in SH-SY5Y cell line","volume":"57","author":"Castillo","year":"2016","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.ejmech.2024.117198_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0163-7258(95)02002-0","article-title":"The pharmacology of galanthamine and its analogues","volume":"68","author":"Harvey","year":"1995","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117198_bib15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00726-022-03167-z","article-title":"Synthesis and biological study of new galanthamine-peptide derivatives designed for prevention and treatment of Alzheimer's disease","volume":"54","author":"Vezenkov","year":"2022","journal-title":"Amino Acids"},{"issue":"22","key":"10.1016\/j.ejmech.2024.117198_bib16","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1021\/jm3009458","article-title":"Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease","volume":"55","author":"Simoni","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117198_bib17","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejmech.2015.10.001","article-title":"Donepezil-like multifunctional agents: design, synthesis, molecular modeling and biological evaluation","volume":"121","author":"Wu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.117198_bib18","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acs.jmedchem.0c01863","article-title":"Kinetics-driven drug design strategy for next-generation acetylcholinesterase inhibitors to clinical candidate","volume":"64","author":"Zhou","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117198_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117198_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2024.04.223","article-title":"TXNIP knockdown protects rats against bupivacaine-induced spinal neurotoxicity via the inhibition of oxidative stress and apoptosis","volume":"219","author":"Zhao","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117198_bib21","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1021\/acs.jmedchem.1c01883","article-title":"Resveratrol-based MTDLs to stimulate defensive and regenerative pathways and block early events in neurodegenerative cascades","volume":"65","author":"Herrera-Arozamena","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117198_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106441","article-title":"Design, synthesis, and evaluation of N-methyl-propargylamine derivates as isoform-selective monoamine oxidases inhibitors for the treatment of nervous system diseases","volume":"134","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117198_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112997","article-title":"ROS-responsive and multifunctional anti-Alzheimer prodrugs: tacrine-ibuprofen hybrids via a phenyl boronate linker","volume":"212","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117198_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116169","article-title":"Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"267","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117198_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-009-0517-0","article-title":"Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis","volume":"118","author":"Sultana","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2024.117198_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114231","article-title":"FSTL1-knockdown improves neural oscillation via decreasing neuronal-inflammation regulating apoptosis in A\u03b21-42 induced AD model mice","volume":"359","author":"Kumari","year":"2023","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117198_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","article-title":"Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction","volume":"706","author":"Maurice","year":"1996","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117198_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13195-017-0304-4","article-title":"Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer's disease by regulating cilia function","volume":"9","author":"Hu","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"issue":"9","key":"10.1016\/j.ejmech.2024.117198_bib29","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of Tau hyperphosphorylation and A\u03b2\u2081\u208b\u2084\u2082 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and \u03c3\u2081 receptor agonist, in a nontransgenic mouse model of Alzheimer's disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.ejmech.2024.117198_bib30","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1021\/acs.jmedchem.4c00483","article-title":"Discovery of ZJCK-6-46: a potent, selective, and orally available dual-specificity tyrosine phosphorylation-regulated kinase 1A inhibitor for the treatment of Alzheimer's disease","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117198_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neubiorev.2018.03.010","article-title":"Applications of the Morris water maze in translational traumatic brain injury research","volume":"88","author":"Tucker","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2024.117198_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111913","article-title":"Design, synthesis and evaluation of diosgenin carbamate derivatives as multitarget anti-Alzheimer's disease agents","volume":"187","author":"Yang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2024.117198_bib33","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer's disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117198_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2015.10.037","article-title":"Effects of harmine, an acetylcholinesterase inhibitor, on spatial learning and memory of APP\/PS1 transgenic mice and scopolamine-induced memory impairment mice","volume":"768","author":"He","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117198_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116695","article-title":"The cellular and molecular processes associated with scopolamine-induced memory deficit: a model of Alzheimer's biomarkers","volume":"233","author":"Tang","year":"2019","journal-title":"Life Sci."},{"issue":"18","key":"10.1016\/j.ejmech.2024.117198_bib36","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1021\/acschemneuro.3c00320","article-title":"Neuroprotective effect of saroglitazar on scopolamine-induced Alzheimer's in rats: insights into the underlying mechanisms","volume":"14","author":"Sandeep","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"24","key":"10.1016\/j.ejmech.2024.117198_bib37","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1021\/jm801131a","article-title":"NO-donating tacrine hybrid compounds improve scopolamine-induced cognition impairment and show less hepatotoxicity","volume":"51","author":"Fang","year":"2008","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2024.117198_bib38","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1021\/acschemneuro.7b00257","article-title":"Rational design and multibiological profiling of novel donepezil-trolox hybrids against Alzheimer's disease, with cholinergic, antioxidant, neuroprotective, and cognition enhancing properties","volume":"8","author":"Cai","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"22","key":"10.1016\/j.ejmech.2024.117198_bib39","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2024.117198_bib40","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117198_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jep.2012.07.019","article-title":"The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or A\u03b2(1-42)-induced cognitive dysfunction in mice","volume":"143","author":"Park","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.ejmech.2024.117198_bib42","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s12272-017-0954-6","article-title":"Liquiritigenin ameliorates memory and cognitive impairment through cholinergic and BDNF pathways in the mouse hippocampus","volume":"40","author":"Ko","year":"2017","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2024.117198_bib43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbi.2018.06.018","article-title":"Neuroprotective effects of INT-777 against A\u03b21-42-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice","volume":"73","author":"Wu","year":"2018","journal-title":"Brain Behav. Immun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:23:21Z","timestamp":1751387001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424010808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"alternative-id":["S0223523424010808"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117198","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of galantamine analogues for cognitive improvement in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117198"}}